Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 47.77408 on 07-10-2025 at 18:20:04
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 1,364.00 at 47.50
Day's Volume: 194,000
Last Close: 47.77408
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 50.42964
Market Capitalisation: -
VWAP: 47.63083
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,364 47.50 OTC Trade
17:52:10 - 07-Oct-25
Unknown* 3,603 47.52407 OTC Trade
17:51:27 - 07-Oct-25
Unknown* 163 47.75607 OTC Trade
17:51:15 - 07-Oct-25
Unknown* 292 47.77408 SI Trade
Negotiated Trade
17:32:05 - 07-Oct-25
Unknown* 272 47.5059 OTC Trade
17:29:23 - 07-Oct-25
Unknown* 1,192 47.5083 OTC Trade
17:29:20 - 07-Oct-25
Unknown* 3,147 47.5059 OTC Trade
17:28:49 - 07-Oct-25
Unknown* 6,399 47.5059 OTC Trade
17:28:19 - 07-Oct-25
Unknown* 4,846 47.5083 OTC Trade
17:28:19 - 07-Oct-25
Unknown* 63 47.5059 OTC Trade
17:28:19 - 07-Oct-25
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Oct 2025 (Tue) 47.77408 47.77408 47.77408 47.77408 194,000
6th Oct 2025 (Mon) 47.63516 47.63516 47.63516 47.63516 252,503
3rd Oct 2025 (Fri) 46.3304 46.3304 46.3304 46.3304 45,499
2nd Oct 2025 (Thu) 45.2919 45.2919 45.2919 45.2919 277,457
1st Oct 2025 (Wed) 46.2931 46.2931 46.2931 46.2931 322,409
30th Sep 2025 (Tue) 47.0768 47.0768 47.0768 47.0768 136,278
29th Sep 2025 (Mon) 47.42 47.42 47.42 47.42 44,557
26th Sep 2025 (Fri) 46.75026 46.75026 46.75026 46.75026 39,463
25th Sep 2025 (Thu) 46.51 46.51 46.51 46.51 67,587
24th Sep 2025 (Wed) 47.43617 47.43617 47.43617 47.43617 86,873
23rd Sep 2025 (Tue) 47.92361 47.92361 47.92361 47.92361 76,350
22nd Sep 2025 (Mon) 48.29 48.29 48.29 48.29 45,861
19th Sep 2025 (Fri) 47.38528 47.38528 47.38528 47.38528 289,916
18th Sep 2025 (Thu) 47.67722 47.67722 47.67722 47.67722 105,198
17th Sep 2025 (Wed) 47.59562 47.59562 47.59562 47.59562 151,057
16th Sep 2025 (Tue) 46.99167 46.99167 46.99167 46.99167 419,971
15th Sep 2025 (Mon) 47.38275 47.38275 47.38275 47.38275 85,913
12th Sep 2025 (Fri) 47.63972 47.63972 47.63972 47.63972 45,501
11th Sep 2025 (Thu) 48.42926 48.42926 48.42926 48.42926 178,532
10th Sep 2025 (Wed) 48.54049 48.54049 48.54049 48.54049 95,565
9th Sep 2025 (Tue) 48.05 48.05 48.05 48.05 163,790
8th Sep 2025 (Mon) 47.73375 47.73375 47.73375 47.73375 130,831
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value9,483.58
Change4.44

Login to your account

Forgot Password?

Not Registered